ADPT

Adaptive Biotechnologies Corporation Common Stock

8.37

USD

+0.07

+0.80%

Feb 19, 15:59 UTC -5

Closed

Pre-Market

7.976

-0.39

-4.71%

Adaptive Biotechnologies Corporation Common Stock Profile

About

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.

Info & Links

CEO

Headquarters

--

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

--

Auditor

Share holders

--

Employees

--

Adaptive Biotechnologies Corporation Common Stock Statistics

Valuation Measures

Market Capitalization²

1.18B

Enterprise Value

1.13B

Enterprise Value/EBITDA(ttm)

-9.36

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

6.87

Price to Book(mrq)

6.07

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

44.07%

Operating Margin(ttm)

-85.10%

Profit Margin(ttm)

-72.39%

Return on Equity(ttm)

-64.65%

Return on Invested Capital(ttm)

-50.81%

Return on Assets(ttm)

-26.45%

Income Statement

Revenue(ttm)

178.96M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

106.88M

EBITDA(ttm)³

-120.65M

Net Income Available to Common(ttm)

-159.49M

Diluted EPS(ttm)

-1.09

Share Statistics

Beta (5Y Monthly)

1.50

52-Week Change

117.40%

S&P 500 52-Week Change

23.49%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

--

Dividend Yield

0.00%

Float⁴

138.43M

% Held by Insiders

6.20%

% Held by Institutions

99.17%

Balance Sheet

Total Cash(mrq)

222.29M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

2.81%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.